Aratana Therapeutics, Inc.. (PETX) NASDAQ
$4.92 - (-)
Market Cap: -
As of 07/17/19 04:00 PM EDT. Market closed.
Aratana Therapeutics, Inc.. (PETX)
NASDAQ
$4.92
- (-)
Market Cap: -
As of 07/17/19 04:00 PM EDT. Market closed.
Add to Portfolio
Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ... read more
Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. read less
COMPANY PROFILE
Sector
Health Technology
Industry
Pharmaceuticals: Generic
CEO Compensation (Base)
$528,390
CEO Compensation (Total)
$2.09M
Sector
Health Technology
Industry
Pharmaceuticals: Generic
CEO Compensation (Base)
$528,390
CEO Compensation (Total)
$2.09M
URL
Address
11400 Tomahawk Creek Parkway, KS, Leawood, 66211.
PRICE CHART FOR ARATANA THERAPEUTICS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
$3.30 - $7.16
Volume
0
Avg. Volume (30 days)
850,576
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
-
Days Range
- - -
52 week range
$3.30 - $7.16
Volume
0
Avg. Volume (30 days)
850,576
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR ARATANA THERAPEUTICS, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ARATANA THERAPEUTICS, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| AYRES JOHN C | SEE REMARKS | Jan 30, 2019 | Sale | $4.19 | 3,125 | 13,094 | 129,889 | Feb 01, 2019, 05:45 PM |
| TOOMAN CRAIG A | President, CEO and CFO | Jan 24, 2019 | Option Exercise | $4.22 | 18,490 | 78,028 | 307,501 | Jan 28, 2019, 05:50 PM |
| St Peter Steven | PRESIDENT AND CEO | Dec 17, 2018 | Sale | $5.85 | 46,094 | 269,788 | 516,626 | Dec 17, 2018, 06:00 PM |
| HEINEN ERNST | Chief Development Officer | Nov 07, 2018 | Sale | $6.95 | 19,308 | 134,191 | 135,694 | Nov 09, 2018, 06:00 PM |
| HEINEN ERNST | Chief Development Officer | Nov 02, 2018 | Sale | $6.95 | 692 | 4,809 | 155,002 | Nov 06, 2018, 06:05 PM |
| St Peter Steven | PRESIDENT AND CEO | Oct 30, 2018 | Sale | $5.86 | 11,513 | 67,454 | 562,720 | Oct 31, 2018, 06:00 PM |
| St Peter Steven | PRESIDENT AND CEO | Sep 21, 2018 | Sale | $6.06 | 75,000 | 454,305 | 574,233 | Sep 21, 2018, 06:31 PM |
| HEINEN ERNST | Chief Development Officer | Aug 14, 2018 | Sale | $5.15 | 1,712 | 8,817 | 155,694 | Aug 14, 2018, 05:32 PM |
| HEINEN ERNST | Chief Development Officer | Aug 13, 2018 | Sale | $5.15 | 8,660 | 44,599 | 157,406 | Aug 14, 2018, 05:32 PM |
| HEINEN ERNST | Chief Development Officer | Aug 10, 2018 | Sale | $5.15 | 1,954 | 10,063 | 166,066 | Aug 10, 2018, 05:45 PM |
| HEINEN ERNST | Chief Development Officer | Aug 08, 2018 | Sale | $5.15 | 2,674 | 13,771 | 168,020 | Aug 10, 2018, 05:45 PM |
| St Peter Steven | PRESIDENT AND CEO | Jul 30, 2018 | Sale | $4.33 | 11,513 | 49,842 | 649,233 | Jul 30, 2018, 05:51 PM |
| Standridge Brent | Chief Operating Officer | Jun 25, 2018 | Sale | $4.56 | 10,000 | 45,644 | 99,967 | Jun 27, 2018, 05:32 PM |
| St Peter Steven | PRESIDENT AND CEO | Apr 30, 2018 | Sale | $5.00 | 11,513 | 57,582 | 660,746 | May 01, 2018, 08:00 PM |
| St Peter Steven | PRESIDENT AND CEO | Apr 30, 2018 | Sale | $5.00 | 11,513 | 57,582 | 660,746 | Apr 30, 2018, 05:49 PM |
| St Peter Steven | PRESIDENT AND CEO | Jan 30, 2018 | Sale | $4.77 | 19,367 | 92,301 | 672,259 | Feb 01, 2018, 05:29 PM |
| TOOMAN CRAIG A | CHIEF FINANCIAL OFFICER | Jan 11, 2018 | Sale | $5.27 | 30,000 | 158,040 | 75,024 | Jan 12, 2018, 05:37 PM |
| TOOMAN CRAIG A | CHIEF FINANCIAL OFFICER | Dec 21, 2017 | Option Exercise | $3.14 | 2,000 | 6,280 | 105,024 | Dec 21, 2017, 06:09 PM |
| St Peter Steven | PRESIDENT AND CEO | Dec 20, 2017 | Option Exercise | $3.14 | 26,667 | 83,734 | 556,026 | Dec 21, 2017, 06:06 PM |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | Dec 01, 2017 | Sale | $5.44 | 562,428 | 3,059,350 | 4,784,854 | Dec 01, 2017, 05:01 PM |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | Nov 30, 2017 | Sale | $5.94 | 211,572 | 1,256,591 | 5,068,326 | Dec 01, 2017, 05:01 PM |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | Nov 29, 2017 | Sale | $6.53 | 116,516 | 761,111 | 5,183,942 | Dec 01, 2017, 05:01 PM |
| St Peter Steven | PRESIDENT AND CEO | Nov 10, 2017 | Sale | $7.00 | 50,000 | 350,000 | 529,359 | Nov 13, 2017, 06:05 PM |
| St Peter Steven | PRESIDENT AND CEO | Oct 02, 2017 | Sale | $6.24 | 50,000 | 312,115 | 579,359 | Oct 04, 2017, 06:00 PM |
| Standridge Brent | Chief Operating Officer | Sep 25, 2017 | Sale | $6.11 | 10,000 | 61,127 | 70,267 | Sep 27, 2017, 06:00 PM |
| HEINEN ERNST | Chief Development Officer | Sep 15, 2017 | Sale | $6.25 | 10,000 | 62,500 | 130,994 | Sep 19, 2017, 06:03 PM |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | May 19, 2017 | Option Exercise | $7.50 | 729,500 | 5,471,250 | 5,184,942 | May 22, 2017, 01:51 PM |
| St Peter Steven | PRESIDENT AND CEO | Apr 17, 2017 | Option Exercise | $3.14 | 46,666 | 146,531 | 629,359 | Apr 18, 2017, 06:06 PM |
| St Peter Steven | PRESIDENT AND CEO | Apr 17, 2017 | Sale | $5.54 | 50,000 | 277,150 | 582,693 | Apr 18, 2017, 06:06 PM |
| St Peter Steven | PRESIDENT AND CEO | Jan 27, 2017 | Sale | $7.72 | 50,000 | 385,875 | 632,693 | Jan 31, 2017, 06:03 PM |
| St Peter Steven | PRESIDENT AND CEO | Dec 15, 2016 | Sale | $7.63 | 50,000 | 381,380 | 542,793 | Dec 16, 2016, 05:49 PM |
| HEINEN ERNST | Chief Development Officer | Oct 03, 2016 | Sale | $10.00 | 10,000 | 100,006 | 115,494 | Oct 04, 2016, 06:01 PM |
| TOOMAN CRAIG A | CHIEF FINANCIAL OFFICER | Sep 09, 2016 | Sale | $9.25 | 30,000 | 277,599 | 72,424 | Sep 12, 2016, 06:04 PM |
| St Peter Steven | PRESIDENT AND CEO | Aug 09, 2016 | Sale | $9.25 | 50,000 | 462,500 | 642,793 | Aug 10, 2016, 06:19 PM |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | Jun 28, 2016 | Sale | $6.25 | 30,000 | 187,500 | 127,503 | Jun 28, 2016, 06:25 PM |
| HEINEN ERNST | Chief Development Officer | Jun 10, 2016 | Sale | $6.72 | 15,000 | 100,862 | 125,494 | Jun 13, 2016, 06:32 PM |
| TOOMAN CRAIG A | CHIEF FINANCIAL OFFICER | Feb 01, 2016 | Sale | $3.36 | 2,806 | 9,436 | 102,424 | Feb 02, 2016, 07:16 PM |
| TOOMAN CRAIG A | CHIEF FINANCIAL OFFICER | Nov 09, 2015 | Sale | $7.52 | 3,620 | 27,238 | 69,980 | Nov 10, 2015, 06:09 PM |
| TOOMAN CRAIG A | CHIEF FINANCIAL OFFICER | Oct 02, 2015 | Sale | $8.06 | 3,250 | 26,188 | 73,600 | Oct 02, 2015, 07:34 PM |
| HEINEN ERNST | Chief Development Officer | Jul 15, 2015 | Sale | $17.06 | 15,000 | 255,831 | 97,494 | Jul 17, 2015, 05:36 PM |
| Rhodes Linda | CHIEF SCIENTIFIC OFFICER | Apr 27, 2015 | Sale | $15.00 | 15,000 | 224,985 | 426,505 | Apr 28, 2015, 06:09 PM |
| Rhodes Linda | CHIEF SCIENTIFIC OFFICER | Mar 06, 2015 | Sale | $20.00 | 20,000 | 400,000 | 421,005 | Mar 06, 2015, 06:34 PM |
| Vander Vort John | Director | Mar 06, 2015 | Sale | $20.01 | 6,137 | 122,776 | 25,000 | Mar 06, 2015, 06:31 PM |
| St Peter Steven | PRESIDENT AND CEO | Jan 13, 2015 | Sale | $19.23 | 75,000 | 1,442,407 | 609,394 | Jan 13, 2015, 06:04 PM |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | Jan 13, 2015 | Sale | $19.00 | 6,300 | 119,700 | 112,803 | Jan 13, 2015, 06:02 PM |
| St Peter Steven | PRESIDENT AND CEO | Jan 02, 2015 | Sale | $17.87 | 25,000 | 446,648 | 684,394 | Jan 06, 2015, 05:05 PM |
| Rhodes Linda | CHIEF SCIENTIFIC OFFICER | Dec 22, 2014 | Sale | $18.00 | 10,000 | 180,000 | 441,005 | Dec 23, 2014, 05:06 PM |
| Rhodes Linda | CHIEF SCIENTIFIC OFFICER | Oct 06, 2014 | Option Exercise | $6.00 | 4,700 | 28,200 | 451,005 | Oct 08, 2014, 05:37 PM |
| St Peter Steven | PRESIDENT AND CEO | Sep 03, 2014 | Option Exercise | $6.00 | 25,000 | 150,000 | 734,394 | Sep 04, 2014, 06:06 PM |
| St Peter Steven | PRESIDENT AND CEO | Sep 02, 2014 | Sale | $11.67 | 25,000 | 291,863 | 709,394 | Sep 04, 2014, 06:06 PM |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | Aug 25, 2014 | Option Exercise | $12.16 | 288 | 3,502 | 119,103 | Aug 26, 2014, 06:27 PM |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | Jul 25, 2014 | Option Exercise | $12.45 | 288 | 3,586 | 119,391 | Jul 28, 2014, 05:05 PM |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | Jul 03, 2014 | Sale | $17.33 | 2,000 | 34,660 | 119,679 | Jul 03, 2014, 04:57 PM |
| Rhodes Linda | CHIEF SCIENTIFIC OFFICER | Jul 01, 2014 | Sale | $16.00 | 10,000 | 160,000 | 446,305 | Jul 03, 2014, 04:54 PM |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | Jun 25, 2014 | Option Exercise | $14.79 | 288 | 4,260 | 121,679 | Jun 26, 2014, 05:04 PM |
| Rhodes Linda | CHIEF SCIENTIFIC OFFICER | Jun 17, 2014 | Sale | $15.00 | 4,626 | 69,390 | 456,305 | Jun 17, 2014, 06:05 PM |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | Jun 16, 2014 | Sale | $13.90 | 8,000 | 111,164 | 121,967 | Jun 16, 2014, 06:49 PM |
| Rhodes Linda | CHIEF SCIENTIFIC OFFICER | Jun 09, 2014 | Sale | $15.00 | 5,374 | 80,610 | 460,931 | Jun 11, 2014, 06:10 PM |
| St Peter Steven | PRESIDENT AND CEO | Jun 02, 2014 | Sale | $13.47 | 25,000 | 336,805 | 734,394 | Jun 02, 2014, 06:55 PM |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | May 25, 2014 | Option Exercise | $12.57 | 288 | 3,620 | 129,967 | May 27, 2014, 05:41 PM |
| HEINEN ERNST | Chief Development Officer | May 05, 2014 | Sale | $13.42 | 10,000 | 134,200 | 95,294 | May 05, 2014, 05:11 PM |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | Apr 25, 2014 | Option Exercise | $13.55 | 288 | 3,902 | 130,255 | Apr 28, 2014, 05:25 PM |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | Mar 26, 2014 | Option Exercise | $19.00 | 4,009 | 76,159 | 131,119 | Mar 28, 2014, 05:12 PM |
| MPM BIOVENTURES V, L.P. | 10% Owner | Mar 10, 2014 | Sale | $20.02 | 600,000 | 12,012,000 | 2,751,048 | Mar 12, 2014, 06:55 PM |
| GADICKE ANSBERT | 10% Owner | Mar 07, 2014 | Sale | $20.16 | 26,713 | 538,534 | 0 | Mar 11, 2014, 04:48 PM |
| Foley Todd | 10% Owner | Mar 07, 2014 | Sale | $19.95 | 12,539 | 250,153 | 0 | Mar 11, 2014, 04:47 PM |
| Lichter Jay | Director | Feb 03, 2014 | Sale | $19.00 | 825,000 | 15,675,000 | 3,345,543 | Feb 05, 2014, 04:29 PM |
| Avalon Ventures IX, L.P. | 10% Owner | Feb 03, 2014 | Sale | $19.00 | 825,000 | 15,675,000 | 3,345,543 | Feb 05, 2014, 04:25 PM |
| MEEUSEN RONALD L | Director | Feb 03, 2014 | Sale | $19.00 | 500,000 | 9,500,000 | 759,857 | Feb 05, 2014, 02:14 PM |
| Lichter Jay | Director | Jul 02, 2013 | Buy | $6.00 | 500,000 | 3,000,000 | 4,170,543 | Feb 04, 2014, 04:54 PM |
| Avalon Ventures IX, L.P. | 10% Owner | Jul 02, 2013 | Buy | $6.00 | 500,000 | 3,000,000 | 4,170,545 | Jul 08, 2013, 07:04 PM |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | Jul 02, 2013 | Buy | $6.00 | 2,000 | 12,000 | 134,552 | Jul 03, 2013, 06:06 PM |
| St Peter Steven | PRESIDENT AND CEO | Jul 02, 2013 | Buy | $6.00 | 8,333 | 49,998 | 529,191 | Jul 03, 2013, 06:04 PM |
| Vander Vort John | Director | Jul 02, 2013 | Buy | $6.00 | 500,000 | 3,000,000 | 4,351,050 | Jul 02, 2013, 05:08 PM |
| MPM BIOVENTURES V, L.P. | 10% Owner | Jul 02, 2013 | Buy | $6.00 | 500,000 | 3,000,000 | 4,351,050 | Jul 02, 2013, 05:06 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| AYRES JOHN C | SEE REMARKS | 01/30/2019 | 13,094 |
| TOOMAN CRAIG A | President, CEO and CFO | 01/24/2019 | 78,028 |
| St Peter Steven | PRESIDENT AND CEO | 12/17/2018 | 269,788 |
| HEINEN ERNST | Chief Development Officer | 11/07/2018 | 134,191 |
| HEINEN ERNST | Chief Development Officer | 11/02/2018 | 4,809 |
| St Peter Steven | PRESIDENT AND CEO | 10/30/2018 | 67,454 |
| St Peter Steven | PRESIDENT AND CEO | 09/21/2018 | 454,305 |
| HEINEN ERNST | Chief Development Officer | 08/14/2018 | 8,817 |
| HEINEN ERNST | Chief Development Officer | 08/13/2018 | 44,599 |
| HEINEN ERNST | Chief Development Officer | 08/10/2018 | 10,063 |
| HEINEN ERNST | Chief Development Officer | 08/08/2018 | 13,771 |
| St Peter Steven | PRESIDENT AND CEO | 07/30/2018 | 49,842 |
| Standridge Brent | Chief Operating Officer | 06/25/2018 | 45,644 |
| St Peter Steven | PRESIDENT AND CEO | 04/30/2018 | 57,582 |
| St Peter Steven | PRESIDENT AND CEO | 04/30/2018 | 57,582 |
| St Peter Steven | PRESIDENT AND CEO | 01/30/2018 | 92,301 |
| TOOMAN CRAIG A | CHIEF FINANCIAL OFFICER | 01/11/2018 | 158,040 |
| TOOMAN CRAIG A | CHIEF FINANCIAL OFFICER | 12/21/2017 | 6,280 |
| St Peter Steven | PRESIDENT AND CEO | 12/20/2017 | 83,734 |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | 12/01/2017 | 3,059,350 |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | 11/30/2017 | 1,256,591 |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | 11/29/2017 | 761,111 |
| St Peter Steven | PRESIDENT AND CEO | 11/10/2017 | 350,000 |
| St Peter Steven | PRESIDENT AND CEO | 10/02/2017 | 312,115 |
| Standridge Brent | Chief Operating Officer | 09/25/2017 | 61,127 |
| HEINEN ERNST | Chief Development Officer | 09/15/2017 | 62,500 |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | 05/19/2017 | 5,471,250 |
| St Peter Steven | PRESIDENT AND CEO | 04/17/2017 | 146,531 |
| St Peter Steven | PRESIDENT AND CEO | 04/17/2017 | 277,150 |
| St Peter Steven | PRESIDENT AND CEO | 01/27/2017 | 385,875 |
| St Peter Steven | PRESIDENT AND CEO | 12/15/2016 | 381,380 |
| HEINEN ERNST | Chief Development Officer | 10/03/2016 | 100,006 |
| TOOMAN CRAIG A | CHIEF FINANCIAL OFFICER | 09/09/2016 | 277,599 |
| St Peter Steven | PRESIDENT AND CEO | 08/09/2016 | 462,500 |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | 06/28/2016 | 187,500 |
| HEINEN ERNST | Chief Development Officer | 06/10/2016 | 100,862 |
| TOOMAN CRAIG A | CHIEF FINANCIAL OFFICER | 02/01/2016 | 9,436 |
| TOOMAN CRAIG A | CHIEF FINANCIAL OFFICER | 11/09/2015 | 27,238 |
| TOOMAN CRAIG A | CHIEF FINANCIAL OFFICER | 10/02/2015 | 26,188 |
| HEINEN ERNST | Chief Development Officer | 07/15/2015 | 255,831 |
| Rhodes Linda | CHIEF SCIENTIFIC OFFICER | 04/27/2015 | 224,985 |
| Rhodes Linda | CHIEF SCIENTIFIC OFFICER | 03/06/2015 | 400,000 |
| Vander Vort John | Director | 03/06/2015 | 122,776 |
| St Peter Steven | PRESIDENT AND CEO | 01/13/2015 | 1,442,407 |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | 01/13/2015 | 119,700 |
| St Peter Steven | PRESIDENT AND CEO | 01/02/2015 | 446,648 |
| Rhodes Linda | CHIEF SCIENTIFIC OFFICER | 12/22/2014 | 180,000 |
| Rhodes Linda | CHIEF SCIENTIFIC OFFICER | 10/06/2014 | 28,200 |
| St Peter Steven | PRESIDENT AND CEO | 09/03/2014 | 150,000 |
| St Peter Steven | PRESIDENT AND CEO | 09/02/2014 | 291,863 |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | 08/25/2014 | 3,502 |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | 07/25/2014 | 3,586 |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | 07/03/2014 | 34,660 |
| Rhodes Linda | CHIEF SCIENTIFIC OFFICER | 07/01/2014 | 160,000 |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | 06/25/2014 | 4,260 |
| Rhodes Linda | CHIEF SCIENTIFIC OFFICER | 06/17/2014 | 69,390 |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | 06/16/2014 | 111,164 |
| Rhodes Linda | CHIEF SCIENTIFIC OFFICER | 06/09/2014 | 80,610 |
| St Peter Steven | PRESIDENT AND CEO | 06/02/2014 | 336,805 |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | 05/25/2014 | 3,620 |
| HEINEN ERNST | Chief Development Officer | 05/05/2014 | 134,200 |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | 04/25/2014 | 3,902 |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | 03/26/2014 | 76,159 |
| MPM BIOVENTURES V, L.P. | 10% Owner | 03/10/2014 | 12,012,000 |
| GADICKE ANSBERT | 10% Owner | 03/07/2014 | 538,534 |
| Foley Todd | 10% Owner | 03/07/2014 | 250,153 |
| Lichter Jay | Director | 02/03/2014 | 15,675,000 |
| Avalon Ventures IX, L.P. | 10% Owner | 02/03/2014 | 15,675,000 |
| MEEUSEN RONALD L | Director | 02/03/2014 | 9,500,000 |
| Lichter Jay | Director | 07/02/2013 | 3,000,000 |
| Avalon Ventures IX, L.P. | 10% Owner | 07/02/2013 | 3,000,000 |
| STEPHANUS JULIA A | CHIEF COMMERCIAL OFFICER | 07/02/2013 | 12,000 |
| St Peter Steven | PRESIDENT AND CEO | 07/02/2013 | 49,998 |
| Vander Vort John | Director | 07/02/2013 | 3,000,000 |
| MPM BIOVENTURES V, L.P. | 10% Owner | 07/02/2013 | 3,000,000 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR ARATANA THERAPEUTICS, INC.
LOADING...